Apoptosis
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
What is Apoptosis? The Apoptotic Pathways and the Caspase Cascade
Targets for Apoptosis
- Pyroptosis(32)
- Caspase(68)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(41)
- Bax(8)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(8)
- IAP(27)
- KEAP1-Nrf2(70)
- MDM2(13)
- p53(124)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(149)
- Other Apoptosis(884)
- Apoptosis Detection(0)
- Caspase Substrate(0)
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Cuproptosis(3)
Products for Apoptosis
- Cat.No. Product Name Information
-
GC11720
17-AAG (KOS953)
BMS 722782, CP 127374, KOS 953, NSC 330507, Tanespimycin
17-AAG(Geldanamycin), a natural benzoquinone ansamycin antibiotic, is the first established inhibitor of Hsp90. -
GC13044
17-DMAG (Alvespimycin) HCl
17-DMAG (Alvespimycin) HCl (17-DMAG hydrochloride; KOS-1022; BMS 826476) is a potent inhibitor of Hsp90, binding to Hsp90 with EC50 of 62±29 nM.
-
GC41983
19,20-Epoxycytochalasin D
19,20-Epoxycytochalasin D is a fungal metabolite that has been found in the endophytic fungus Nemania sp.
-
GC48423
19-O-Acetylchaetoglobosin A
Chaetoglobosin A Acetate
A fungal metabolite with actin polymerization inhibitory and cytotoxic activities -
GC39296
1G244
1G244 is a potent DPP8/9 inhibitor with IC50s of 12 nM and 84 nM, respectively. 1G244 does not inhibit DPPIV and DPPII. 1G244 induces apoptosis in multiple myeloma cells and has anti-myeloma effects.
-
GC46508
2',2'-Difluoro-2'-deoxyuridine
dFdU
An active metabolite of gemcitabine -
GC41612
2'-O-Methylguanosine
2'-O-Methylguanosine is a modified nucleoside that is produced in tRNAs by the action of tRNA guanosine-2'-O-methyltransferase, using S-adenosyl-L-methionine as a substrate.
-
GC12258
2,3-DCPE hydrochloride
-
GC40947
2,3-Dimethoxy-5-methyl-p-benzoquinone
Coenzyme Q0, CoQ0
2,3-Dimethoxy-5-methyl-p-benzoquinone (CoQ0) is a potent, oral active ubiquinone compound can be derived from Antrodia cinnamomea. -
GC68452
2,4,6-Triiodophenol
-
GC46057
2,5-Dihydroxycinnamic Acid phenethyl ester
An inhibitor of 5-LO
-
GC45324
2,5-dimethyl Celecoxib
DMC
-
GN10065
2-Atractylenolide
2-Atractylenolide
-
GC40675
2-deoxy-Artemisinin
2-deoxy-Artemisinin is an inactive metabolite of the antimalarial agent artemisinin.
-
GC17430
2-Deoxy-D-glucose
2-DG
2-Deoxy-D-glucose (2DG), is a glucose analogue, act as competitive glycolytic inhibitor. -
GC49223
2-deoxy-D-Glucose-13C6
2-DG-13C6
An internal standard for the quantification of 2-deoxy-D-glucose -
GC46545
2-Fluoroadenine
F-Ade, NSC 27364
A heterocyclic building block -
GC12545
2-HBA
Bis(2-hydroxybenzylidene)acetone
indirect inducer of enzymes that catalyze detoxification reactions through the Keap1-Nrf2-ARE pathway. -
GC62777
2-Methoxy-4-vinylphenol
2-Methoxy-4-vinylphenol (2M4VP), a naturally Germination inhibitor, exerts potent anti-inflammatory effects.
-
GC38318
2-Methoxycinnamaldehyde
2-Methoxycinnamaldehyde (o-Methoxycinnamaldehyde) is a natural compound of Cinnamomum cassia, with antitumor activity. 2-Methoxycinnamaldehyde inhibits proliferation and induces apoptosis by mitochondrial membrane potential (ΔΨm) loss, activation of both caspase-3 and caspase-9. 2-Methoxycinnamaldehyde effectively inhibits platelet-derived growth factor (PDGF)-induced HASMC migration.
-
GC15084
2-Methoxyestradiol (2-MeOE2)
2Hydroxyestradiol 2methyl ether, 2ME2, NSC 659853, Panzem
2-Methoxyestradiol (2-MeOE2/2-Me) is an HIF-1α inhibitor. -
GC68043
2-tert-Butyl-1,4-benzoquinone
-
GC15355
2-Trifluoromethyl-2'-methoxychalcone
Nrf2 activator
-
GN10800
20(S)-NotoginsenosideR2
-
GC46528
25-hydroxy Cholesterol-d6
An internal standard for the quantification of 25hydroxy cholesterol
-
GC48449
28-(Poc-amino)betulin
-
GC48482
28-Acetylbetulin
28-acetoxy Betulin, 28-O-Acetylbetulin, C-28-Acetylbetulin
A lupane triterpenoid with anti-inflammatory and anticancer activities -
GC62033
3α-Hydroxy pravastatin sodium
3α-Isopravastatin, R-416
3α-Hydroxy pravastatin sodium is the major metabolite of Pravastatin. -
GC35112
3'-Hydroxypterostilbene
3'-Hydroxypterostilbene is a Pterostilbene analogue. 3'-Hydroxypterostilbene inhibits the growth of COLO 205, HCT-116 and HT-29 cells with IC50s of 9.0, 40.2 and 70.9 ?M, respectively. 3'-Hydroxypterostilbene significantly down-regulates PI3K/Akt and MAPKs signaling pathways and effectively inhibits the growth of human colon cancer cells by inducing apoptosis and autophagy. 3'-Hydroxypterostilbene can be used for the research of cancer.
-
GC12791
3,3'-Diindolylmethane
DIM
A phytochemical with antiradiation and chemopreventative effects -
GC20020
3,4-Dihydroxyflavone
3',4'-DHF
-
GC42237
3,5-dimethyl PIT-1
PtdIns-(3,4,5)-P3 (PIP3) serves as an anchor for the binding of signal transduction proteins bearing pleckstrin homology (PH) domains such as phosphatidylinositol 3-kinase (PI3K) or PTEN.
-
GC42240
3,6-dichloro-benzo[b]thiophene-2-Carboxylic Acid
3,6-dichloro-benzo[b]thiophene-2-Carboxylic acid is an inhibitor of myeloid cell leukemia 1 (Mcl-1) with a Ki value of 59 μM for binding of FITC-Mcl-1-BH2 peptide binding to Mcl-1.
-
GC64762
3,6-Dihydroxyflavone
3,6-Dihydroxyflavone is an anti-cancer agent. 3,6-Dihydroxyflavone dose- and time-dependently decreases cell viability and induces apoptosis by activating caspase cascade, cleaving poly (ADP-ribose) polymerase (PARP). 3,6-Dihydroxyflavone increases intracellular oxidative stress and lipid peroxidation.
-
GC46583
3-Amino-2,6-Piperidinedione
α-Aminoglutarimide, 3-Aminoglutarimide, Glutamimide
An active metabolite of (±)-thalidomide -
GC49849
3-Aminosalicylic Acid
3-ASA, NSC 285111
A salicylic acid derivative -
GC35106
3-Dehydrotrametenolic acid
3-?Dehydrotrametenolic acid, isolated from the sclerotium of Poria cocos, is a lactate dehydrogenase (LDH) inhibitor. 3-?Dehydrotrametenolic acid promotes adipocyte differentiation in vitro and acts as an insulin sensitizer in vivo. 3-?Dehydrotrametenolic acid induces apoptosis and has anticancer activity.
-
GC68537
3-IN-PP1
3-IN-PP1 is a protein kinase D (PKD) inhibitor. It has effective and broad PKD inhibitory activity against PKD1, PKD2, and PKD3 with IC50 values of 108, 94, and 108 nM respectively. Additionally, 3-IN-PP1 is a broad-spectrum anticancer agent that inhibits the growth of various tumor cells. It can be used in cancer research.
-
GC74668
3-Methoxy-9H-Carbazole
3-Methoxy-9H-Carbazole induces caspase-3 activities and the cellular generation of eactive oxygen species.
-
GC17394
3-Nitropropionic acid
β-Nitropropionic Acid, 3-NP, NSC 64266
3-Nitropropionic acid (β-Nitropropionic acid) is an irreversible inhibitor of succinate dehydrogenase. -
GC35099
3-O-Acetyloleanolic acid
3-Acetyloleanolic Acid
3-O-Acetyloleanolic acid (3AOA), an oleanolic acid derivative isolated from the seeds of Vigna sinensis K., induces in cancer and also exhibits anti-angiogenesis activity. -
GC60507
3-O-Methylgallic acid
3-O-Methylgallic acid (3,4-Dihydroxy-5-methoxybenzoic acid) is an anthocyanin metabolite and has potent antioxidant capacity. 3-O-methylgallic acid inhibits Caco-2 cell proliferation with an IC50 value of 24.1 μM. 3-O-methylgallic acid also induces cell apoptosis and has anti-cancer effects.
-
GC91154
33-BCRP Inhibitor
A BCRP inhibitor
-
GC32767
3BDO
3-Benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one
A butyrolactone derivative and autophagy inhibitor -
GC45354
4β-Hydroxywithanolide E
NSC 212509
A withanolide with anti-inflammatory and anticancer activities -
GC48437
4'-Acetyl Chrysomycin A
A bacterial metabolite with antibacterial and anticancer activities
-
GC48436
4'-Acetylchrysomycin B
-
GC42346
4-bromo A23187
4-Bromocalcimycin
4-bromo A23187 is a halogenated analog of the highly selective calcium ionophore A23187.
-
GC42401
4-hydroperoxy Cyclophosphamide
4-OOH-CY
4-hydroperoxy Cyclophosphamide, the active metabolite of cyclophosphamide, can cross-link DNA and induce T cell apoptosis independently of caspase receptor activation. It also activates the mitochondrial death pathway through the production of reactive oxygen species (ROS). -
GC30896
4-Hydroxybenzyl alcohol
NSC 227926, p-Hydroxybenzyl Alcohol
A phenol with diverse biological activities -
GC33815
4-Hydroxyphenylacetic acid
4-HPAA, p-HPAA, para-HPAA, p-Hydroxyphenylacetic Acid, para-Hydroxyphenylacetic Acid, NSC 25066, NSC 27460
A phenolic acid with anti-inflammatory activity -
GC35138
4-Methyldaphnetin
4-Methyldaphnetin is a precursor in the synthesis of derivatives of 4-methyl coumarin. 4-Methyldaphnetin has potent, selective anti-proliferative and apoptosis-inducing effects on several cancer cell lines. 4-Methyldaphnetin possesses radical scavenging property and strongly inhibits membrane lipid peroxidation.
-
GC68231
4-Methylsalicylic acid
-
GC31648
4-Octyl Itaconate
4-Octyl Itaconate (4-OI) is a cell-permeable itaconate derivative.
-
GC49127
4-oxo Cyclophosphamide
4-keto CP, 4-keto Cyclophosphamide, NSC 139488, 4-oxo CP
An inactive metabolite of cyclophosphamide -
GC45352
4-oxo Withaferin A
4-Dehydrowithaferin A
4-oxo Withaferin A is the analogue of withaferin A. Withaferin A is a withanolide isolated from Withania somnifera. 4-oxo Withaferin A has the potential for the research of multiple myeloma. -
GC45353
4-oxo-27-TBDMS Withaferin A
4-oxo-27-TBDMS Withaferin A, a withaferin A derivative, exhibits potent antiproliferative effects on the tumor cells.4-oxo-27-TBDMS Withaferin A induces tumor cells apoptosis. 4-oxo-27-TBDMS Withaferin A is a anticancer agent.
-
GC60525
4-Vinylphenol (10%w/w in propylene glycol)
4-Vinylphenol is found in the medicinal herb Hedyotis diffusa Willd, wild rice and is also the metabolite of p-coumaric and ferulic acid by lactic acid bacteria in wine. 4-Vinylphenol induces apoptosis and inhibits blood vessels formation and suppresses invasive breast tumor growth in vivo.
-
GC10468
4EGI-1
eIF4E/eIF4G Interaction Inhibitor
Competitive eIF4E/eIF4G interaction inhibitor -
GC71507
5'-Methylthioadenosine-13C6
5'-Methylthioadenosine-13C6 is the 13C-labeled 5'-Methylthioadenosine.
-
GC35150
5,7,4'-Trimethoxyflavone
5,7,4'-Trimethoxyflavone is isolated from Kaempferia parviflora (KP) that is a famous medicinal plant from Thailand. 5,7,4'-Trimethoxyflavone induces apoptosis, as evidenced by increments of sub-G1 phase, DNA fragmentation, annexin-V/PI staining, the Bax/Bcl-xL ratio, proteolytic activation of caspase-3, and degradation of poly (ADP-ribose) polymerase (PARP) protein.5,7,4'-Trimethoxyflavone is significantly effective at inhibiting proliferation of SNU-16 human gastric cancer cells in a concentration dependent manner.
-
GN10629
5,7-dihydroxychromone
-
GC63972
5,7-Dimethoxyflavanone
5,7-Dimethoxyflavanone shows potent antimutagenic activity against MeIQ mutagenesis in Ames test using the S.
-
GC52227
5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone
(±)-δ-(3,4-Dihydroxyphenyl)-γ-Valerolactone, 5-(3',4'-Dihydroxyphenyl)-γ-VL
An active metabolite of various polyphenols -
GC90889
5-(3'-Hydroxyphenyl)-γ-Valerolactone
A metabolite of various polyphenols
-
GC35147
5-(N,N-Hexamethylene)-amiloride
HMA
An amiloride derivative with diverse biological activities -
GC90549
5-Aminoimidazole-4-carboxamide (hydrate)
A synthetic precursor
-
GC45356
5-Aminolevulinic Acid (hydrochloride)
-
GC68562
5-Aminolevulinic acid-13C-1 hydrochloride
5-ALA-13C-1 hydrochloride; δ-Aminolevulinic acid-13C-1 hydrochloride; 5-Amino-4-oxopentanoic acid-13C-1 hydrochloride
5-Aminolevulinic acid-13C-1 (5-ALA-13C-1) hydrochloride is a 13C-labeled form of 5-Aminolevulinic acid hydrochloride. 5-Aminolevulinic acid hydrochloride (5-ALA hydrochloride) is an intermediate in the biosynthesis of heme in the body and serves as a precursor to porphyrins.
-
GC71833
5-Aminolevulinic acid-d2 hydrochloride
5-Aminolevulinic acid-d2 (hydrochloride) is deuterium labeled 5-Aminolevulinic acid (hydrochloride).
-
GC46681
5-Bromouridine
(-)-5-Bromouridine, BrU, BrUrd, NSC 38296
A brominated uridine analog -
GC42545
5-Fluorouracil-13C,15N2
5-FU-13C,15N2
5-Fluorouracil-13C,15N2 is intended for use as an internal standard for the quantification of 5-flurouracil by GC- or LC-MS. -
GC46705
5-Methoxycanthinone
5-Methoxycanthin-6-one, NSC 88929
5-Methoxycanthinone is an orally active inhibitor of Leishmania strains. -
GC42586
6α-hydroxy Paclitaxel
6α-hydroxy Taxol
6α-hydroxy Paclitaxel is a primary metabolite of the anticancer compound paclitaxel, produced by the action of the cytochrome P450 isoform CYP2C8. -
GC63958
6α-Hydroxy Paclitaxel-d5
6α-Hydroxy Paclitaxel-d5 is the deuterium labeled 6α-Hydroxy paclitaxel. 6α-Hydroxy paclitaxel is a primary metabolite of Paclitaxel. 6α-Hydroxy paclitaxel retains a time-dependent effect on organic anion-transporting polypeptides 1B1/SLCO1B1 (OATP1B1) with similar inhibition potency to Paclitaxel, whereas it no longer showed time-dependent inhibition of OATP1B3. 6α-Hydroxy paclitaxel can be used for the research of cancer.
-
GC45772
6(5H)-Phenanthridinone
NSC 11021, NSC 40943, NSC 61083
An inhibitor of PARP1 and 2 -
GC90659
6-epi COTC
A derivative of COTC with anticancer activity
-
GN10093
6-gingerol
-
GC49429
6-keto Lithocholic Acid
5β-Cholanic Acid-3α-ol-6-one, 6-KLCA, 6-keto LCA, 6-oxo LCA, 6-oxo Lithocholic Acid, 6-keto Lithocholate, 6-oxo Lithocholate
A metabolite of lithocholic acid -
GC35184
7,3',4'-Tri-O-methylluteolin
7,3',4'-Tri-O-methylluteolin (5-Hydroxy-3',4',7-trimethoxyflavone), a flavonoid compound, possesses potent anti-inflammatory effects in LPS-induced macrophage cell line mediated by inhibition of release of inflammatory mediators, NO, PGE2, and pro-inflammatory cytokines.
-
GC45673
7,8-Dihydroneopterin
D-erythro-7,8-Dihydroneopterin
An antioxidant -
GC16853
7,8-Dihydroxyflavone
7,8-DHF
7,8-Dihydroxyflavone is a naturally-occurring plant-based flavone and high-affinity tyrosine kinase receptor B (TrkB) agonist with an IC50 value of 0.26μM. -
GC35190
7-Ethylcamptothecin
SN-22
7-Ethylcamptothecin is one of camptothecin analogues. camptothecin (CPT), a cytotoxic alkaloid isolated from Camptotheca acuminate, is shown to have strong antitumor activity against L1210 leukemia and Walker 256 carcinosarcoma models. -
GC42616
7-oxo Staurosporine
BMY 41950, RK-1409
7-oxo Staurosporine is an antibiotic originally isolated from S.
-
GC16037
7BIO
7-Bromoindirubin-3’-oxime
caspase independent nonapoptotic cell death inducer -
GC46741
8(E),10(E),12(Z)-Octadecatrienoic Acid
α-Calendic Acid, Calendic Acid, Calendulic Acid, trans,trans,cis-8,10,12-Octadecatrienoic Acid
A conjugated PUFA -
GC42622
8-bromo-Cyclic AMP
8-Bromoadenosine 3',5'-cyclic monophosphate, 8-Br-cAMP, 8-bromo-cAMP, NSC 171719
8-bromo-Cyclic AMP is a brominated derivative of cAMP that remains long-acting due to its resistance to degradation by cAMP phosphodiesterase. -
GC46744
8-Bromoadenosine 5′-triphosphate (sodium salt hydrate)
8-bromo ATP
A neuropeptide with diverse biological activities -
GC49275
8-Oxycoptisine
8-Oxocoptisine
8-Oxycoptisine is a natural protoberberine alkaloid with anti-cancer activity. -
GC17119
8-Prenylnaringenin
Flavaprenin,8-PN
estrogen receptor inhibitor -
GC41642
9(E),11(E),13(E)-Octadecatrienoic Acid
β-Eleostearic Acid, β-ESA
9(E),11(E),13(E)-Octadecatrienoic acid (β-ESA) is a conjugated polyunsaturated fatty acid that is found in plant seed oils and in mixtures of conjugated linolenic acids synthesized by the alkaline isomerization of linolenic acid. -
GC41643
9(Z),11(E),13(E)-Octadecatrienoic Acid
αEleostearic Acid, αESA, LAF 237
9(Z),11(E),13(E)-Octadecatrienoic Acid (α-ESA) is a conjugated polyunsaturated fatty acid commonly found in plant seed oil. -
GC40785
9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester
αESA ethyl ester, Ethyl αeleostearate
9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester (α-ESA) is a conjugated polyunsaturated fatty acid commonly found in plant seed oil. -
GC40710
9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester
αESA methyl ester, Methyl αeleostearate
9Z,11E,13E-octadecatrienoic acid (α-ESA) is a conjugated polyunsaturated fatty acid commonly found in plant seed oil. -
GC70659
9-cis-Retinoic acid-d5
9-cis-Retinoic acid-d5 is the deuterium labeled 9-cis-Retinoic acid.
-
GC39152
9-ING-41
Elraglusib
9-ING-41 is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic drugs. -
GN10035
9-Methoxycamptothecin
-
GC45960
9c(i472)
15-LOX-1 Inhibitor i472
9c(i472) is a potent inhibitor of 15-LOX-1 (15-lipoxygenase-1) with an IC50 value of 0.19 μM. -
GC50465
A 410099.1
High affinity XIAP antagonist; active in vivo
-
GC17512
A-1155463
BCL-XL inhibitor, potent and selective